Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Diffuse In‐Stent Restenosis

Diffuse In‐Stent Restenosis Stent restenosis, especially the diffuse pattern, has developed into a significant clinical and economical problem. It has been estimated that up to 250,000 patients developed in‐stent restenosis in 2,000 alone, two thirds of them can be expected to have diffuse in‐stent restenosis, which is difficult to treat because of high recurrence rates. None of the conventionally available interventional treatment modalities provides optimal long‐term results. Intravascular radiation therapy is currently the only effective percutaneous therapy, for combating in‐stent restenosis. Late thrombotic complications have largely been eliminated by extended antiplatelet regimens. Geographical miss, a major reason for recurrence of in‐stent restenosis after brachytherapy, can be reduced by an improved radiation technique. The first preliminary data on drug‐eluting stents, showing only minimal neointimal proliferation at 6‐month postimplantation, could represent a major breakthrough in the quest to solve restenosis. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Interventional Cardiology Wiley

Diffuse In‐Stent Restenosis

Journal of Interventional Cardiology , Volume 14 (6) – Dec 1, 2001

Loading next page...
 
/lp/wiley/diffuse-in-stent-restenosis-qEX7Aa0zUs

References (125)

Publisher
Wiley
Copyright
Copyright © 2001 Wiley Subscription Services, Inc., A Wiley Company
ISSN
0896-4327
eISSN
1540-8183
DOI
10.1111/j.1540-8183.2001.tb00376.x
Publisher site
See Article on Publisher Site

Abstract

Stent restenosis, especially the diffuse pattern, has developed into a significant clinical and economical problem. It has been estimated that up to 250,000 patients developed in‐stent restenosis in 2,000 alone, two thirds of them can be expected to have diffuse in‐stent restenosis, which is difficult to treat because of high recurrence rates. None of the conventionally available interventional treatment modalities provides optimal long‐term results. Intravascular radiation therapy is currently the only effective percutaneous therapy, for combating in‐stent restenosis. Late thrombotic complications have largely been eliminated by extended antiplatelet regimens. Geographical miss, a major reason for recurrence of in‐stent restenosis after brachytherapy, can be reduced by an improved radiation technique. The first preliminary data on drug‐eluting stents, showing only minimal neointimal proliferation at 6‐month postimplantation, could represent a major breakthrough in the quest to solve restenosis.

Journal

Journal of Interventional CardiologyWiley

Published: Dec 1, 2001

There are no references for this article.